HDAC6 and glioma: Together, these studies suggest that ciliated tumor cells may be more sensitive to HDAC6 inhibitors and raise an important and unanswered question as to whether HDAC6 signaling and promotion of tumor cell proliferation are dependent on cilia in glioma.